|
Volumn 148, Issue 1, 2004, Pages 1-4
|
Tackling the challenge of cardiovascular disease burden in developing countries
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ACETYLSALICYLIC ACID;
ANTILIPEMIC AGENT;
ATORVASTATIN;
BETA ADRENERGIC RECEPTOR BLOCKING AGENT;
DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;
DIURETIC AGENT;
ENALAPRIL;
HYDROCHLOROTHIAZIDE;
STATIN;
CARDIOVASCULAR DISEASE;
DEVELOPING COUNTRY;
DRUG COST;
EDITORIAL;
EPIDEMIOLOGICAL DATA;
HEALTH CARE COST;
HEALTH CARE PLANNING;
HEALTH CARE POLICY;
HEALTH PROMOTION;
HUMAN;
INDUSTRIALIZATION;
MEDICAL RESEARCH;
PRIORITY JOURNAL;
RISK FACTOR;
SOCIOECONOMICS;
TOBACCO;
URBANIZATION;
CARDIOVASCULAR DISEASES;
DEVELOPING COUNTRIES;
DIET;
DISEASE OUTBREAKS;
HEALTH POLICY;
HEALTH PROMOTION;
HUMANS;
RISK FACTORS;
|
EID: 3142580826
PISSN: 00028703
EISSN: None
Source Type: Journal
DOI: 10.1016/j.ahj.2004.03.045 Document Type: Editorial |
Times cited : (50)
|
References (9)
|